Chemotherapy News and Research

Latest Chemotherapy News and Research

Pfizer-BioNTech’s COVID-19 vaccine effective and safe for use among cancer patients

Researchers in Israel have conducted a study showing that the use of Pfizer-BioNTech’s coronavirus disease 2019 (COVID-19) vaccine appears to be safe and effective among patients with cancer.

11 Jul 2021

Stimulating immune cells to form special structures can potentiate pancreatic cancer chemotherapy

A new study from Queen Mary University of London has demonstrated that immune cells can be stimulated to assemble into special structures within pancreatic cancer such that, at least in a pre-clinical model, researchers can demonstrate an improvement in the efficacy of chemotherapy.

9 Jul 2021

Genetic map reveals potential new treatment for aggressive childhood brain tumor

A genetic map of an aggressive childhood brain tumor called medulloblastoma has helped researchers identify a new generation anti-cancer drug that can be repurposed as an effective treatment for the disease.

7 Jul 2021

Chemotherapy destabilizes gut microbiome in cancer patients

New research in BMC Cancer has shown myelosuppressive chemotherapy destabilizes gut microbiome in patients with solid organ cancers.

6 Jul 2021

Researchers seek to find a cure for the deadliest solid tumor in children

Australian researchers and oncologists have been awarded $2.4 million to investigate the causes and treatments for neuroblastoma, the deadliest and most common solid tumor in children under the age of five.

5 Jul 2021

Researchers highlight easily adoptable methods to improve outcomes for patients with gastroesophageal cancer

Two Roswell Park Comprehensive Cancer Center experts were invited to present new insights on treatment of gastroesophageal cancers during the European Society for Medical Oncology World Congress on Gastrointestinal Cancer 2021.

2 Jul 2021

Engineered T cells prevent translational shutdown in SARS-CoV-2 infected cells

In a paper recently uploaded to the preprint server bioRxiv* by Schamel et al. (June 25th, 2021) engineered T cells against SARS-CoV-2 are tested against a range of cells in vitro, finding that the treatment could be used to restore cellular immune function and suppress SARS-CoV-2.

1 Jul 2021

Lung cancer patients should be screened for MET oncogene amplification, research suggests

Research by investigators at Mayo Clinic Cancer Center suggests that physicians should screen patients with lung cancer for MET amplification/overexpression before determining a treatment strategy.

1 Jul 2021

Flinders University trial to evaluate new blood test for personalized cancer treatment

A blood test to help guide the treatment of oesophageal, stomach and bowel cancers will be evaluated in a new Flinders University trial set to get underway.

1 Jul 2021

COVID-19 vaccines are effective in 94% of cancer patients, shows study

In a U.S. and Swiss study, nearly all patients with cancer developed good immune response to the COVID-19 mRNA vaccines three to four weeks after receiving their second dose, but the fact that a small group of the patients exhibited no response raised questions about how their protection against the virus will be addressed moving forward.

1 Jul 2021

RESILIENCE project aims to reduce the burden of cardiovascular disease in cancer survivors

Cancer patients are a vulnerable population prone to develop cardiovascular complications. Among other factors, some anticancer therapies can induce adverse cardiovascular effects.

30 Jun 2021

FDA approves alternative component of chemotherapy regimen to treat acute lymphoblastic leukemia

Today, the U.S. Food and Drug Administration approved Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) as a component of a chemotherapy regimen to treat acute lymphoblastic leukemia and lymphoblastic lymphoma in adult and pediatric patients who are allergic to the E. coli-derived asparaginase products used most commonly for treatment.

30 Jun 2021

UTA chemist develops cancer medication that uses light to destroy tumor cells

A chemist at The University of Texas at Arlington is developing a cancer medication that uses light to target and destroy tumor cells in a process known as photodynamic therapy (PDT).

29 Jun 2021

Research shines new light on deadly medulloblastoma metastases

With advances in medical science driving progress against childhood brain tumors, today three out of four young patients survive at least five years beyond diagnosis. However, the outcomes look grim when malignant cells spread, or metastasize.

29 Jun 2021

New tool allows surgeons to pinpoint breast tumors more easily

Breast surgeons at Hackensack Meridian Hackensack University Medical Center have a new tool that allows them to pinpoint breast tumors more easily, with many benefits to the patient.

29 Jun 2021

Moffitt awarded $10.2 million grant to investigate lung cancer metabolism

The National Cancer Institute has awarded the Lung Cancer Metabolism Working Group at Moffitt Cancer Center with a Research Program Project Grant (P01CA250984).

28 Jun 2021

Study examines effect of sorafenib in patients with advanced hepatocellular carcinoma

Oncotarget published "Insulin-like growth factor 1/Child-Turcotte-Pugh composite score as a predictor of treatment outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib" which reported that this study investigated the association of the IGF/CTP score with overall survival and progression-free survival of HCC patients treated with sorafenib.

28 Jun 2021

Anti-cancer prodrug can benefit cancer patients

Unlike conventional cancer drugs that attack and kill cancer cells directly, anti-cancer immunotherapy, which kills cancer cells by strengthening the body's immunity, is a novel type of cancer treatment currently attracting increased attention. Unfortunately, a minority of cancer patients who have some degree of pre-existing immunity only benefit from anti-cancer immunotherapy.

28 Jun 2021

Antagonism of glucocorticoid receptors promotes apoptosis in solid tumor cells

Oncotarget published "Glucocorticoid receptor antagonism promotes apoptosis in solid tumor cells" which reported that to guide studies in cancer patients, relacorilant, an investigational selective GR modulator that antagonizes cortisol activity, was assessed in various tumor types, with multiple cytotoxic combination partners, and in the presence of physiological cortisol concentrations.

28 Jun 2021

New microscopy technique reveals the cellular make-up of Wilm's tumors

A new technique to look at tumors under the microscope has revealed the cellular make-up of Wilm's tumors, a childhood kidney cancer, in unprecedented detail.

24 Jun 2021

Chemotherapy News and Research

Latest Chemotherapy News and Research

Pfizer-BioNTech’s COVID-19 vaccine effective and safe for use among cancer patients

Stimulating immune cells to form special structures can potentiate pancreatic cancer chemotherapy

Genetic map reveals potential new treatment for aggressive childhood brain tumor

Chemotherapy destabilizes gut microbiome in cancer patients

Researchers seek to find a cure for the deadliest solid tumor in children

Researchers highlight easily adoptable methods to improve outcomes for patients with gastroesophageal cancer

Engineered T cells prevent translational shutdown in SARS-CoV-2 infected cells

Lung cancer patients should be screened for MET oncogene amplification, research suggests

Flinders University trial to evaluate new blood test for personalized cancer treatment

COVID-19 vaccines are effective in 94% of cancer patients, shows study

RESILIENCE project aims to reduce the burden of cardiovascular disease in cancer survivors

FDA approves alternative component of chemotherapy regimen to treat acute lymphoblastic leukemia

UTA chemist develops cancer medication that uses light to destroy tumor cells

Research shines new light on deadly medulloblastoma metastases

New tool allows surgeons to pinpoint breast tumors more easily

Moffitt awarded $10.2 million grant to investigate lung cancer metabolism

Study examines effect of sorafenib in patients with advanced hepatocellular carcinoma

Anti-cancer prodrug can benefit cancer patients

Antagonism of glucocorticoid receptors promotes apoptosis in solid tumor cells

New microscopy technique reveals the cellular make-up of Wilm's tumors

Cancer Research - Second Edition eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Newsletters you may be interested in